Clinical trial

Sitagliptin Treatment in Diabetic COVID-19 Positive Patients

NCT04382794

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-05-14

PhaseN/A

Study timeline

Study start (actual)2020-05-14Date precision: day

Registry last updated2020-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Covid19unresolved

Interventions

Retrospective case-control analysisDRUG

Sponsors & collaborators

University of Milanlead sponsor

Papa Giovanni XXIII Hospitalcollaborator

Fondazione IRCCS Policlinico San Matteo di Paviacollaborator

Humanitas Hospital, Italycollaborator

Ospedale dell'Angelo, Venezia-Mestrecollaborator

University of Paviacollaborator

Mapped research locations

PaviaItaly2 MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04382794 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.